AAAAAA
Results: 26-50/70
Authors:
FERRON GM
ROCHDI M
JUSKO WJ
SCHERRMANN JM
Citation: Gm. Ferron et al., ORAL ABSORPTION CHARACTERISTICS AND PHARMACOKINETICS OF COLCHICINE INHEALTHY-VOLUNTEERS AFTER SINGLE AND MULTIPLE DOSES, Journal of clinical pharmacology, 36(10), 1996, pp. 874-883
Authors:
LEMAUFF B
LEMEUR Y
HOURMANT M
DEBRAY M
BOEFFARD F
ALBERICI G
SOULILLOU JP
SCHERRMANN JM
Citation: B. Lemauff et al., A DOSE-SEARCHING TRIAL OF AN ANTI-LFA1 MONOCLONAL-ANTIBODY IN FIRST KIDNEY-TRANSPLANT RECIPIENTS, Kidney international, 49, 1996, pp. 44-50
Authors:
PEPINCOVATTA S
LUTSCH C
GRANDGEORGE M
LANG J
SCHERRMANN JM
Citation: S. Pepincovatta et al., IMMUNOREACTIVITY AND PHARMACOKINETICS OF HORSE ANTI-SCORPION VENOM F(AB')(2)-SCORPION VENOM INTERACTIONS, Toxicology and applied pharmacology, 141(1), 1996, pp. 272-277
Authors:
RIZZO N
PADOIN C
PALOMBO S
SCHERRMANN JM
GIRRE C
Citation: N. Rizzo et al., OMEPRAZOLE AND LANSOPRAZOLE ARE NOT INDUCERS OF CYTOCHROME P4501A2 UNDER CONVENTIONAL THERAPEUTIC CONDITIONS, European Journal of Clinical Pharmacology, 49(6), 1996, pp. 491-495
Authors:
DRION N
LEMAIRE M
LEFAUCONNIER JM
SCHERRMANN JM
Citation: N. Drion et al., ROLE OF P-GLYCOPROTEIN IN THE BLOOD-BRAIN TRANSPORT OF COLCHICINE ANDVINBLASTINE, Journal of neurochemistry, 67(4), 1996, pp. 1688-1693
Authors:
RAGUSI C
BOSCHI G
RIPS R
SCHERRMANN JM
Citation: C. Ragusi et al., FACILITATION OF IMIPRAMINE EFFLUX FROM THE BRAIN BY SYSTEMIC SPECIFICANTIBODIES, British Journal of Pharmacology, 118(8), 1996, pp. 2152-2156
Authors:
BENCHETRIT E
SCHERRMANN JM
LEVY M
Citation: E. Benchetrit et al., COLCHICINE IN BREAST-MILK OF PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER, Arthritis and rheumatism, 39(7), 1996, pp. 1213-1217
Authors:
BOSCHI G
LAUNAY N
RIPS R
SCHERRMANN JM
Citation: G. Boschi et al., BRAIN MICRODIALYSIS IN THE MOUSE, Journal of pharmacological and toxicological methods, 33(1), 1995, pp. 29-33
Authors:
FERRON G
DEBRAY M
BUNEAUX F
BAUD FJ
SCHERRMANN JM
Citation: G. Ferron et al., PHARMACOKINETICS OF LITHIUM IN PLASMA AND RED-BLOOD-CELLS IN ACUTE AND CHRONIC INTOXICATED PATIENTS, International journal of clinical pharmacology and therapeutics, 33(6), 1995, pp. 351-355
Authors:
SCHERRMANN JM
SANDOUK P
BARJAVEL MJ
STAIN F
PLOTKINE M
BHARGAVA BN
Citation: Jm. Scherrmann et al., ANALGESIC EFFECTS AND PLASMA AND EXTRACELLULAR FLUID (ECF) PHARMACOKINETICS OF MORPHINE AND MORPHINE-6-GLUCURONIDE IN THE RAT, The FASEB journal, 9(3), 1995, pp. 99-99
Authors:
PEPIN S
LUTSCH C
GRANDGEORGE M
SCHERRMANN JM
Citation: S. Pepin et al., SNAKE F(AB')(2) ANTIVENOM FROM HYPERIMMUNIZED HORSE - PHARMACOKINETICS FOLLOWING INTRAVENOUS AND INTRAMUSCULAR ADMINISTRATIONS IN RABBITS, Pharmaceutical research, 12(10), 1995, pp. 1470-1473
Authors:
CHAPPEY O
SCHERRMANN JM
Citation: O. Chappey et Jm. Scherrmann, COLCHICINE - RECENT PHARMACOKINETIC AND C LINICAL PHARMACOLOGICAL DATA, La Revue de medecine interne, 16(10), 1995, pp. 782-789
Authors:
SANDOUK P
CHAPPEY O
DYVOIRE MB
SCHERRMANN JM
Citation: P. Sandouk et al., PHARMACOKINETICS OF THIOCOLCHICOSIDE IN HUMANS USING A SPECIFIC RADIOIMMUNOASSAY, Therapeutic drug monitoring, 17(5), 1995, pp. 544-548
Authors:
SANDRE C
GENITEAULEGENDRE M
SCHERRMANN JM
QUERO AM
LABARRE C
Citation: C. Sandre et al., IMMUNOREACTIVITY OF ENDOGENOUS DIGITALIS-LIKE SUBSTANCES IN CORD-BLOOD SERA STUDIED WITH ANTIDIGITOXIN MONOCLONAL-ANTIBODIES, Therapeutic drug monitoring, 17(1), 1995, pp. 19-24
Authors:
BAZINREDUREAU M
GIRES P
CHAPELLE P
MARTINET M
SCHERRMANN JM
Citation: M. Bazinredureau et al., IMMUNOGLOBULIN-G, F(AB')(2), AND FAB FRAGMENT UPTAKE KINETICS IN ISOLATED-PERFUSED RAT-LIVER AND RAT HEPATIC CELLS, Drug metabolism and disposition, 23(12), 1995, pp. 1400-1406
Authors:
FAESSEL H
HOUZE P
BAUD FJ
SCHERRMANN JM
Citation: H. Faessel et al., 4-METHYLPYRAZOLE MONITORING DURING HEMODIALYSIS OF ETHYLENE-GLYCOL INTOXICATED PATIENTS, European Journal of Clinical Pharmacology, 49(3), 1995, pp. 211-213
Authors:
BAUD FJ
SABOURAUD A
VICAUT E
TABOULET P
LANG J
BISMUTH C
ROUZIOUX JM
SCHERRMANN JM
Citation: Fj. Baud et al., TREATMENT OF SEVERE COLCHICINE OVERDOSE WITH COLCHICINE-SPECIFIC FAB FRAGMENTS, The New England journal of medicine, 332(10), 1995, pp. 642-645
Authors:
STAIN F
BARJAVEL MJ
SANDOUK P
PLOTKINE M
SCHERRMANN JM
BHARGAVA HN
Citation: F. Stain et al., ANALGESIC RESPONSE AND PLASMA AND BRAIN EXTRACELLULAR FLUID PHARMACOKINETICS OF MORPHINE AND MORPHINE-6-BETA-D-GLUCURONIDE IN THE RAT, The Journal of pharmacology and experimental therapeutics, 274(2), 1995, pp. 852-857
Authors:
BARJAVEL MJ
SCHERRMANN JM
BHARGAVA HN
Citation: Mj. Barjavel et al., RELATIONSHIP BETWEEN MORPHINE ANALGESIA AND CORTICAL EXTRACELLULAR FLUID LEVELS OF MORPHINE AND ITS METABOLITES IN THE RAT - A MICRODIALYSIS STUDY, British Journal of Pharmacology, 116(8), 1995, pp. 3205-3210
Authors:
CANO NJ
NAVARROTEULON I
DEBRAY M
PIECHACZYK M
SCHERRMANN JM
Citation: Nj. Cano et al., AFFINITY AND DOSE-DEPENDENT DIGOXIN NA(-SPECIFIC ANTIBODIES()K(+)ATPASE DISSOCIATION BY MONOCLONAL DIGOXIN), Biochemical pharmacology, 50(11), 1995, pp. 1867-1872
Authors:
SABOURAUD A
CHAPPEY O
DUPIN T
SCHERRMANN JM
Citation: A. Sabouraud et al., BINDING OF COLCHICINE AND THIOCOLCHICOSIDE TO HUMAN SERUM-PROTEINS AND BLOOD-CELLS, International journal of clinical pharmacology and therapeutics, 32(8), 1994, pp. 429-432
Authors:
SCHERRMANN JM
Citation: Jm. Scherrmann, ANTIBODY TREATMENT OF TOXIN POISONING - RECENT ADVANCES, Journal of toxicology. Clinical toxicology, 32(4), 1994, pp. 363-375
Authors:
BENMOUSSA K
SABOURAUD A
SCHERRMANN JM
BOURRE JM
Citation: K. Benmoussa et al., CYCLOSPORINE ABSORPTION IS IMPAIRED BY THE FAT SUBSTITUTES, SUCROSE POLYESTER AND TRICARBALLYLATE TRIESTER, IN THE RAT, Pharmaceutical research, 11(10), 1994, pp. 1458-1461
Authors:
BENCHETRIT E
SCHERRMANN JM
ZYLBERKATZ E
LEVY M
Citation: E. Benchetrit et al., COLCHICINE DISPOSITION IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER WITH PENAL IMPAIRMENT, Journal of rheumatology, 21(4), 1994, pp. 710-713
Authors:
CHAPPEY O
NIEL E
DERVICHIAN M
WAUTIER JL
SCHERRMANN JM
CATTAN D
Citation: O. Chappey et al., COLCHICINE CONCENTRATION IN LEUKOCYTES OF PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER, British journal of clinical pharmacology, 38(1), 1994, pp. 87-89